Transaction #3906 · Form 4 · 0001342655-25-000007
GoodRx Holdings, Inc. · Stock award · Class A Common Stock
GoodRx Holdings, Inc. · Transacted October 31, 2025 · Filed November 3, 2025
What does this filing report?
An SEC Form 4 filing for GoodRx Holdings, Inc. records a stock award involving Class A Common Stock on October 31, 2025. The reported quantity was 3,065. The filing date is November 3, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- GoodRx Holdings, Inc.
- Company CIK
- 0001809519
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 3,065
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 185,269
- Ownership description
- Not reported
- SEC acceptance time
- Nov 3, 2025, 7:57 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Wagner Scott ↗
Director
CIK 0001342655
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on November 30, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
- F2
- Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.